Your browser doesn't support javascript.
loading
Artificial Hair: By the Dawn to Automatic Biofibre® Hair Implant.
Roccia, Maria; França, Katlein; Castillo, David; Tchernev, Georgi; Wollina, Uwe; Tirant, Michael; Valle, Yan; Guarneri, Claudio; Fioranelli, Massimo; Lotti, Torello.
Afiliación
  • Roccia M; University B.I.S. Group of Institutions, Punjab Technical University, Punjab, India.
  • França K; University of Miami School of Medicine, Miami, Florida, United States.
  • Castillo D; University of Miami School of Medicine, Miami, Florida, United States.
  • Tchernev G; Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, Sofia, Bulgaria.
  • Wollina U; Onkoderma, Private Clinic for Dermatologic Surgery, Onkoderma - Policlinic for Dermatology and Dermatologic Surgery, Sofia, Bulgaria.
  • Tirant M; Städtisches Klinikum Dresden, Department of Dermatology and Allergology, 01067 Dresden, Germany.
  • Valle Y; Psoriasis & Skin Clinic, Melbourne, Australia.
  • Guarneri C; Vitiligo Research Foundation, New York, United States.
  • Fioranelli M; Universita degli Studi di Messina, Clinical and Experimental Medicine, Section of Dermatology, Institute of Dermatology, A.O.U. "G. Martino" , Messina 98122, Italy.
  • Lotti T; G. Marconi University, Department of Nuclear Physics, Subnuclear and Radiation, Via Plinio 44, Rome 00197, Italy.
Open Access Maced J Med Sci ; 6(1): 156-162, 2018 Jan 25.
Article en En | MEDLINE | ID: mdl-29484017
Since the beginning of the twentieth century, there have been attempts at creating artificial hair to treat baldness. Major evolution took place at the end of 1970's when, unfortunately, artificial hair treatments were applied without appropriate medical controls, resulting in sub-standard results from the use of unsuitable materials and technique. The large improper use of this technique in North America from no medical personnel and with dangerous fibres led the Food and Drug Administration (FDA) to suspend the procedure in 1983. In Europe, a new trial on artificial hair procedure started at the beginning of 1990's. In 1995 the European Union (UE) recognised the artificial hair implant as a legitimate medical treatment and outlined the rules related to that procedure. In 1996, biocompatible fibres (Biofibre®) produced by Medicap® Italy were approved by the UE Authorities and by the Australian Therapeutic Goods Administration (TGA) as medical devices for hair implant. An effective medical protocol was developed during the following years to provide correct guidelines for appropriate treatment, and to reduce possible related complications. Automatic Biofibre® hair implant represents the last achievement in this hair restoration technique with significant advantages for the patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Open Access Maced J Med Sci Año: 2018 Tipo del documento: Article País de afiliación: India Pais de publicación: Macedonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Open Access Maced J Med Sci Año: 2018 Tipo del documento: Article País de afiliación: India Pais de publicación: Macedonia